Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.43)
# 929
Out of 5,135 analysts
96
Total ratings
39.36%
Success rate
8.03%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Initiates: Overweight | $23 | $5.50 | +318.18% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $11.24 | +167.02% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $328.93 | +264.82% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $4.01 | +274.06% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $19.59 | +272.64% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.69 | +1,379.29% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $491.49 | +83.12% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $32.27 | +132.41% | 1 | Dec 18, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $7.51 | +858.72% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $9.09 | +296.04% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $24.07 | +224.05% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $12.50 | +60.00% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $6.17 | +321.39% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $4 | $1.25 | +220.00% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.60 | +2,066.67% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $38.61 | +275.55% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $30.15 | +69.15% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.32 | +354.55% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $15.00 | +220.00% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $80.30 | +15.82% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $8.29 | +804.70% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $73.18 | +43.48% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $35.76 | +3.47% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $6.21 | +318.68% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.88 | +3,092.34% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $43.43 | +123.35% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.12 | +259.85% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.46 | +460.54% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.57 | +183.82% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $10.03 | +19.64% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.37 | +1,312.87% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.17 | +591.24% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.59 | +186.23% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $54.85 | +45.85% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $68.36 | +36.04% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.65 | +113.88% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.25 | +1,176.19% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.99 | +1,911.67% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $82.99 | -57.83% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.86 | +527.71% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $6.80 | +2,473.53% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $66.98 | +7.49% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $13.96 | +258.17% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.63 | +6,238.14% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.54 | +3,245.72% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.76 | +2,564.97% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $105.10 | -26.74% | 1 | Jul 31, 2020 |
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $5.50
Upside: +318.18%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $11.24
Upside: +167.02%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $328.93
Upside: +264.82%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $4.01
Upside: +274.06%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $19.59
Upside: +272.64%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.69
Upside: +1,379.29%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $491.49
Upside: +83.12%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $32.27
Upside: +132.41%
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $7.51
Upside: +858.72%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.09
Upside: +296.04%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $24.07
Upside: +224.05%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $12.50
Upside: +60.00%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.17
Upside: +321.39%
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.25
Upside: +220.00%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.60
Upside: +2,066.67%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $38.61
Upside: +275.55%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $30.15
Upside: +69.15%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.32
Upside: +354.55%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $15.00
Upside: +220.00%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $80.30
Upside: +15.82%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $8.29
Upside: +804.70%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $73.18
Upside: +43.48%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $35.76
Upside: +3.47%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $6.21
Upside: +318.68%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.88
Upside: +3,092.34%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $43.43
Upside: +123.35%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.12
Upside: +259.85%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.46
Upside: +460.54%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.57
Upside: +183.82%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $10.03
Upside: +19.64%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.37
Upside: +1,312.87%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.17
Upside: +591.24%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.59
Upside: +186.23%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $54.85
Upside: +45.85%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $68.36
Upside: +36.04%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.65
Upside: +113.88%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.25
Upside: +1,176.19%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.99
Upside: +1,911.67%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $82.99
Upside: -57.83%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.86
Upside: +527.71%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $6.80
Upside: +2,473.53%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $66.98
Upside: +7.49%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $13.96
Upside: +258.17%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.63
Upside: +6,238.14%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.54
Upside: +3,245.72%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.76
Upside: +2,564.97%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $105.10
Upside: -26.74%